Mithra Pharmaceuticals SA

Mithra Pharmaceuticals SA is a leading Belgian biotech company that specializes in developing, manufacturing, and commercializing innovative women's health products. The company's primary objective is to enhance women's health and well-being by providing safe, effective, and affordable solutions for contraception, fertility, and menopause. Mithra's product portfolio comprises hormonal contraceptives, hormone therapy for menopause, and fertility treatments. The company's proprietary technologies, including Estetrol (E4), a natural estrogen, and Donesta, a non-hormonal treatment for menopause, have the potential to revolutionize women's health. Mithra is committed to sustainability and ethical business practices, and its state-of-the-art manufacturing facility in Belgium is designed to minimize environmental impact. With a global presence and partnerships with leading pharmaceutical companies, Mithra is poised to become a major player in the women's health market.